Celldex Therapeutics Inc (NAS:CLDX)
$ 36.92 0.6 (1.65%) Market Cap: 2.43 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 2.90 GF Score: 62/100

Q2 2020 Celldex Therapeutics Inc Earnings Call Transcript

Aug 06, 2020 / 08:30PM GMT
Release Date Price: $11.71 (+1.39%)
Operator

Welcome to the Celldex Therapeutics Mid-year 2020 Conference Call. My name is James, and I'll be your operator for today's call. (Operator Instructions).

And then I'd like to turn the call over to Sarah Cavanaugh. Sarah, you may begin.

Sarah Cavanaugh
Celldex Therapeutics, Inc. - SVP of Corporate Affairs & Administration

Thank you very much. Good afternoon and thank you all for joining us.

With me on the call today are Anthony Marucci, co-founder, President and CEO of Celldex, Dr. Tibor Keler, co-founder Executive Vice President and Chief Scientific Officer, Dr. Diane Young, Senior Vice President and Chief Medical Officer. Sam Martin, Senior Vice President and Chief Financial Officer, Dr. Margo Heath-Chiozzi, Senior Vice President of Regulatory and Dr. Diego Alvarado, Senior Director of Research.

Before we begin our discussion, I'd like to mention that today's speakers will be making forward-looking statements. Such statements reflect on current views with respect to future events and are based on assumptions and subject to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot